Logo

GE Healthcare

DNA Script Preparing Launch of Benchtop Enzymatic Synthesizer for 'DNA on Demand'
Premium

The Syntax instrument, available later this year, will initially be able to make batches of 96 oligos of 60-mer length at a time with same-day turnaround.

RevoluGen, GE Healthcare Life Sciences Ink DNA Extraction Product Manufacturing Deal

The product uses spin columns to extract high molecular weight DNA with an average length of 100 kb or more from animal and bacterial cells.

Roche-GE Partnership Integrating Molecular Data Into Navify Tumor Board
Premium

The partners are preparing to release two updates to Navify Tumor Board that support automatic importation of structured Foundation Medicine test reports.

NeoGenomics Completes Clarient Acquisition

The cancer genetics testing provider acquired its new business unit from GE Healthcare.

With Clarient Purchase, NeoGenomics Hoping to Offer Most Comprehensive Cancer Genetics Test Menu
Premium

By buying Clarient, NeoGenomics hopes to move closer to its goal of becoming America's top cancer genetic testing lab.

Oct 21, 2015

NeoGenomics to Acquire Clarient From GE

Jul 14, 2015

Axiogenesis Inks Sublicensing Agreement with GE Healthcare for Stem Cell IP

Dec 4, 2014

Broad Licenses CRISPR/Cas9 IP to GE Healthcare, Sigma-Aldrich

Nov 4, 2014

IP Roundup: GE, Luminex, and University of Tokyo Win US Patents
Premium

Oct 8, 2014

GE/Clarient Setting Up Lab Network, Database to Advance Personalized Rx for GSK, Other Pharmas
Premium

Sep 30, 2014

GE Healthcare's Clarient, GSK Creating Clinical Lab Network to Improve Cancer Dx

Sep 25, 2014

IP Update: Recent Patents Awarded to Alnylam, GE Healthcare, Sanofi, and More
Premium

Sep 4, 2014

Product Watch: GE Healthcare Illustra Single-Cell DNA Amplification Kit
Premium

Aug 21, 2014

IP Update: Recent Patents Awarded to Alnylam, Baxter, GE Healthcare, and More
Premium

Aug 20, 2014

GE Healthcare to Open US Life Sciences HQ in Massachusetts

Aug 15, 2014

Fluidigm Refining CyTOF Imaging Platform in Anticipation of 2015 Commercial Release
Premium

May 8, 2014

Applied Market Watch: GE, NetBio Forensics System; Thermo Fisher Salmonella Assay
Premium

Mar 24, 2014

GE Finalizes Acquisition of Certain Thermo Fisher Assets

Mar 14, 2014

Stanford, Zurich Teams Develop Mass Spec-based Proteomics Technologies for Targeted Tissue Imaging
Premium

Feb 11, 2014

IP Watch: Life Tech, GE Healthcare, BioMerieux, Qiagen, Others Win US Patents
Premium

Jan 31, 2014

FTC Says Sale of Certain Thermo Fisher Assets to GE Healthcare is Required for Life Tech Deal OK

Jan 30, 2014

Dx Focus: Clarient to Offer BioMerieux's BRAF CDx
Premium

Jan 6, 2014

GE Buying Thermo Fisher Businesses for $1.06B

Dec 13, 2013

GE Studies Demonstrate Use of MultiOmyx Platform for Lymphoma Diagnosis, Breast Cancer Research
Premium

Oct 23, 2013

People in the News: Jay Flatley, Greg Heath, Justin Johnson, Fei Lu, Biserka Bacic-Toplek, More
Premium

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.